SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Karyopharm Therapeutics Reports Submission Of Supplemental New Drug Application For XPOVIO As Treatment For Patients With Multiple Myeloma After At Least One Prior Line Of Therapy

Benzinga · 05/20/2020 12:18